Skip to main content
. 2022 May 14;3(4):358–367. doi: 10.1016/j.hroo.2022.05.004

Table 1.

Baseline characteristics

Characteristic All patients (N = 121) Successful (N = 107) Failed (N = 14) P value
 Age, y 74 ± 12 74 ± 12 75 ± 8 .82
 Female 30 (25) 26 (24) 4 (29) .73
Medical history
 HTN 91 (75) 80 (75) 11 (79) .76
 DM 44 (36) 40 (37) 4 (29) .52
 CAD 69 (57) 59 (55) 10 (71) .25
 AF 50 (41) 44 (41) 6 (43) .75
 Ischemic cardiomyopathy 59 (49) 49 (46) 10 (71) .08
 Baseline NYHA class 3 or 4 64 (53) 56 (52) 8 (57) .42
 Baseline NYHA 2.5 ± 0.9 2.5 ± 0.8 2.7 ± 0.8 .54
Echocardiographic parameters
 LVEF 35 ± 9 35 ± 9 34 ± 9 .55
 LVEDD (mm) 55 ± 12 54 ± 12 61 ± 8 .05
 LVESV (mL) 96 ± 49 95 ± 46 99 ± 52 .06
 LVEDV (mL) 138 ± 62 136 ± 61 142 ± 54 .10
 LA volume index (mL/m2) 55 ± 31 54 ± 30 58 ± 33 .04
Electrocardiographic parameters:
 Baseline QRS (ms) 157 ± 20 156 ± 20 172±16 <.01
 Baseline QRS >150 ms 76 (63) 62 (58) 14 (100) <.01

Values are mean ± SD or n (%).

AF = atrial fibrillation; CAD = coronary artery disease; DM = diabetes mellitus; HTN = hypertension; LA = left atrial; LVEDD = left ventricular end-diastolic diameter; LVEDV = left ventricular end-diastolic volume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; NYHA = New York Heart Association.